delamanid
Showing 1 - 25 of 30
Tuberculosis Trial (GSK3036656, Bedaquiline, Delamanid)
Recruiting
- Tuberculosis
- GSK3036656
- +3 more
-
Cape Town, South AfricaGSK Investigational Site
Jan 24, 2023
Pulmonary Tuberculosis Trial (Delamanid, Bedaquiline, OPC-167832, and Sutezolid (DBOS), Pretomanid, Bedaquiline, OPC-167832, and
Not yet recruiting
- Pulmonary Tuberculosis
- Delamanid, Bedaquiline, OPC-167832, and Sutezolid (DBOS)
- +3 more
- (no location specified)
Jul 25, 2023
Tuberculosis, Pulmonary, HIV Trial in Port-au-Prince, Cape Town (Bedaquiline, Clofazimine, Pyrazinamide)
Not yet recruiting
- Tuberculosis, Pulmonary
- HIV
- Bedaquiline
- +6 more
-
Port-au-Prince, Haiti
- +1 more
Nov 11, 2022
Pulmonary TB Trial in South Africa (Delamanid + Bedaquiline + OPC-167832 10 mg, Delamanid + Bedaquiline + OPC-167832 30 mg,
Recruiting
- Pulmonary TB
- Delamanid + Bedaquiline + OPC-167832 10 mg
- +3 more
-
Tembisa, Gauteng, South Africa
- +7 more
Jun 30, 2022
Tuberculosis, Pulmonary, Other Specified Pulmonary Tuberculosis Trial in Cape Town, Mbeya, Mwanza (BTZ-043, Bedaquiline,
Not yet recruiting
- Tuberculosis, Pulmonary
- Other Specified Pulmonary Tuberculosis
- BTZ-043
- +3 more
-
Cape Town, South Africa
- +3 more
Jun 22, 2023
Tuberculosis, Multidrug-Resistant Trial in Dasmariñas, Hanoi (Delamanid, Levofloxacin, Bedaquiline)
Recruiting
- Tuberculosis, Multidrug-Resistant
- Delamanid
- +4 more
-
Dasmariñas, Philippines
- +1 more
Jun 21, 2022
Tuberculosis, Pre-XDR-TB, Extensively Drug-Resistant Tuberculosis Trial in Port Elizabeth (Bedaquiline Oral Tablet, Linezolid
Active, not recruiting
- Tuberculosis
- +4 more
- Bedaquiline Oral Tablet
- +7 more
-
Port Elizabeth, Eastern Cape, South Africa
- +1 more
Oct 20, 2022
Infections and Infestations, Pulmonary Tuberculosis Trial in South Africa, Tanzania (Delpazolid, Bedaquiline, Delamanid,
Active, not recruiting
- Infections and Infestations
- Pulmonary Tuberculosis
- Delpazolid
- Bedaquiline, Delamanid, Moxifloxacin
-
Tembisa, Gauteng, South Africa
- +4 more
Sep 13, 2022
Tuberculosis, HIV Trial in Lima, Cape Town (Bedaquiline, Delamanid, Dolutegravir)
Pulmonary Tuberculosis, Other Specified Pulmonary Tuberculosis Trial in Worldwide (Sutezolid, Rifampicin, Isoniazid)
Recruiting
- Pulmonary Tuberculosis
- Other Specified Pulmonary Tuberculosis
- Sutezolid
- +6 more
-
Lambaréné, Gabon
- +7 more
Apr 17, 2023
Expand New Drugs for TB [endTB]
Completed
- Tuberculosis, Multidrug-Resistant
- This is a non-intervention observational study
-
Abovyan, Armenia
- +15 more
Jun 9, 2022
Tuberculosis, Pulmonary, Tuberculosis Infection Trial in Worldwide (Rifabutin, Delamanid, Bedaquiline)
Not yet recruiting
- Tuberculosis, Pulmonary
- Tuberculosis Infection
- Rifabutin
- +7 more
-
Denver, Colorado
- +14 more
Mar 2, 2023
Tuberculosis Trial in Ogre, Siauliai, Vilnius (Delamanid, Optimized Background Regimen (OBR))
Terminated
- Tuberculosis
- Delamanid
- Optimized Background Regimen (OBR)
-
Ogre, Latvia
- +2 more
Oct 14, 2021
Tuberculosis, Multidrug-Resistant, Tuberculosis, Tuberculosis, Pulmonary Trial in Worldwide (Linezolid 600 mg, Linezolid 1200 mg
Recruiting
- Tuberculosis, Multidrug-Resistant
- +2 more
- Linezolid 600 mg
- +7 more
-
Gaborone, South-East District, Botswana
- +16 more
Dec 13, 2022
Tuberculosis, Multidrug-Resistant Trial in Worldwide (Delamanid, OBR)
Tuberculosis, Multidrug-Resistant, Infection, Bacterial, Pulmonary Tuberculoses Trial in Worldwide (Bedaquiline, Delamanid,
Active, not recruiting
- Tuberculosis, Multidrug-Resistant
- +2 more
- Bedaquiline
- +7 more
-
Tbilisi, Georgia
- +11 more
Feb 14, 2022
Tuberculosis, MDR Trial in Worldwide (Delamanid (DLM), Isoniazid (INH), Pyridoxine (vitamin B6))
Recruiting
- Tuberculosis, MDR
- Delamanid (DLM)
- +2 more
-
Gaborone, South-East District, Botswana
- +26 more
Sep 22, 2022
Tuberculosis, Multidrug-Resistant, Tuberculosis, Pulmonary Tuberculoses Trial in Worldwide (Bedaquiline 100 MG, Delamanid 50 MG
Recruiting
- Tuberculosis, Multidrug-Resistant
- +5 more
- Bedaquiline 100 MG
- +4 more
-
Pune, India
- +9 more
Mar 2, 2022
Pulmonary Tuberculosis, Rifampicin-resistant Tuberculosis Trial in China (Bedaquiline, Delamanid, Contezolid)
Not yet recruiting
- Pulmonary Tuberculosis
- Rifampicin-resistant Tuberculosis
- Bedaquiline
- +11 more
-
Beijing, Beijing, China
- +37 more
Oct 11, 2023
Tuberculosis, Pulmonary, Tuberculosis, Multidrug Resistant, Extensively Drug-Resistant Tuberculosis Trial in Worldwide
Completed
- Tuberculosis, Pulmonary
- +2 more
- Delamanid
- +2 more
-
San Antonio, Texas
- +16 more
Nov 1, 2021
Pharmacometrics to Advance Novel Regimens for Drug-resistant
Recruiting
- Multi-drug Resistant Tuberculosis
-
Almaty, Kazakhstan
- +6 more
Nov 1, 2022
MDR-TB Trial in Shanghai (PRS Regimen V, MDR-TB Treatment Regimen(WHO))
Recruiting
- MDR-TB
- PRS Regimen V
- MDR-TB Treatment Regimen(WHO)
-
Shanghai, ChinaShanghai Pulmonary Hospital
Aug 4, 2022
Multidrug-resistant Tuberculosis Trial in Worldwide (Delamanid + OBR, Placebo + OBR)
Completed
- Multidrug-resistant Tuberculosis
- Delamanid + OBR
- Placebo + OBR
-
Tartu, Estonia
- +16 more
May 13, 2019